Langdurige behandeling met pentraxine-2 bij IPF

Bronnen:

1. Raghu G, Van den Blink B, Hamblin MJ, et al. Long-term treatment with recombinant human pentraxin 2 protein in patients with idiopathic pulmonary fibrosis: an open-label extension study. Lancet Respir Med. 2019 May 20. [Epub ahead of print]